1.Simultaneous Determination of Palmatine, Berberine and Jateorhizine in Jinji Capsules by QAMS
Yanmo YANG ; Jianrong MIU ; Hai LIN
China Pharmacist 2014;(9):1470-1472
Objective: To establish a quantitative analysis of multi-components by single marker ( QAMS ) for determining the three alkaloids in Jinji capsules. Methods:With the typical composition palmatine as the internal standard, the relative correction fac-tor ( RCF) between the palmatine and berberine or jateorhizine was respectively established, and the content of berberine and jateorhiz-ine was respectively calculated by QAMS. An external standard method was used to determine the three alkaloids, and the calculated values were compared with the estimated values by Pearson correlation coefficient. Results:There was no significant difference between the calculated values in QAMS and the estimated values in the external standard method, and the RCF was credible. Conclusion:The new method is feasible and accurate to evaluate the contents of the three alkaloids in Jinji capsules.
2.Risk factors for post-post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with benign biliary diseases
Hai SUN ; Fengshen ZHANG ; Xiaoming DENG ; Lin YANG ; Xing YANG
Journal of Third Military Medical University 2003;0(08):-
0.05).By univariate analysis,the diameter of common bile duct less than 10 mm and sphincter of Oddis dysfunction(SOD) and mutiple cannulation of the pancreatic duct were all statistically different(P
8.Prevention of aseptic loosening prothesis of alendronate in beagle:abiomechanical study
Hai MENG ; Songhua YAN ; Lin YANG ; Ai GAO
International Journal of Surgery 2015;42(5):314-316,封3
Objective To investigate effect of alendronate on prevention of aseptic loosening prothesis.Method Twelve beagles which had been implanted a titanium plug in femur were divided into two groups randomly,one received alendronate,and the other placebo as control.After 12 weeks,all beagles were sacrificed.specimens of femur were studied by biomechanical test.Independent sample t test was used for statistical analyses.Results The pull-out strength of the experimental group was higher than that of the control (P < 0.05),and the torsion strength was also higher in the experimental group(P < 0.05).Conclusion The therapy of alendronate can change the bone strength,inhibit aseptic loosening of prosthesis in beagle and could be a good drug for the prevention and treatment of aseptic loosening prothesis.
9.Solution and prognostic analysis of hypotony after primary operation of severe ocular trauma
Bao-Jie, HOU ; Ya-Lin, MU ; Hai-Yang, WU ; Qing, XU ; Hai, TAO ; Jie, ZHAO
International Eye Science 2006;6(6):1263-1266
· AIM: To explore the effects of C3F8 tamponade on hypotony on or after primary operation and the prognosis of severe ocular trauma.· METHODS: Twenty-six cases (26 eyes) of severe ocular trauma were treated with pure C3F8 tamponade on or after primary operation. IOP was observed, and the curative effect of C3F8 tamponade was observed on secondary operation with prognosis evaluated.· RESULTS: Hypotony improved in 23 eyes postoperatively,in which 18 eyes with edematous and cloudy cornea, 15 eyes had clear cornea after gas tamponade. Retina was reattached under the gas action in 21 eyes during the secondary operation. Visual acuity improved in 22 eyes, remained unchanged in 3 eyes and decreased in 1 eye during the follow-up of 3-12months.· CONCLUSION: Application of pure C3F8 tamponade on or after primary operation can effectively improve hypotony after severe ocular trauma and benefit a better prognosis.
10.Oral medication of statins retards the progression of benign prostatic hyperplasia and lower urinary tract symptoms.
Ming-Gen YANG ; Zhou-Da ZHENG ; Hai-Li LIN ; Zhi-Ming ZHUANG ; Tian-Qi LIN
National Journal of Andrology 2014;20(9):798-802
OBJECTIVETo determine whether oral statins can delay the progression of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
METHODSWe conducted a retrospective cohort study of 50-69-year-old males who came for physical examination in our hospital between January 2003 and December 2008. We designed the inclusion criteria, followed them up for 5 years, and investigated the relationship of oral statins with the clinical progression of BPH and LUTS.
RESULTSTotally, 653 men met the inclusion criteria and were included in this study, of whom 283 were treated with oral statins (group 1) while the other 370 with none (group 2). There were no statistically significant differences between the two groups in age and baseline IPSS, Qmax, and prostate volume (PV) (P > 0.05). During the follow-up, 24 cases in group 1 and 35 cases in group 2 were excluded for obvious dys-uria. A gradual increase was observed in IPSS in both groups 1 and 2 year by year from the baseline to the 5th year of follow-up, but significantly lower in the former group (4.27 +/- 1.16, 4.63 +/- 1.05, 5.27 +/- 0.96, 6.41 +/- 1.04, 7.21 +/- 1.21, and 7.93 +/-1.50) than in the latter (4.24 +/- 1.35, 5.26 +/- 1.23, 6.84 +/- 1.20, 8.75 +/- 1.84, 10.82 +/- 3.01, and 12.98 +/- 4.21) (P < 0.01); a gradual decrease was seen in Qmax, though markedly higher in group 1 ([26.56 +/- 2.09], [24.06 +/- 1.94], [21.33 +/- 1.66], [19.24 +/- 1.54], [17.44 +/- 1.53], and [16.27 +/- 1.37] ml/s) than in group 2 ([26.74 +/- 2.40], [23.62 +/- 2.01], [20.63 +/- 1.69], [17.72 +/- 1.48], [14.82 +/- 1.11], and [11.86 +/- 1.24] ml/s) (P < 0.01); and a gradual increase was found in PV, but remarkably smaller in the former group ([19.82 +/- 4.94], [22.60 +/- 4.99], [25.80 +/- 5.20], [27.92 +/- 5.05], [29.11 +/- 5.24], and [29.97 +/- 5.26] ml) than in the latter ([20.21 +/- 4.78], [24.30 +/- 4.98], [28.50 +/- 5.14], [32.84 +/- 4.77], [36.99 +/- 4.78], and [40.90 +/- 4.78] ml) (P < 0.01). Longer medication of statins was associated with better efficacy.
CONCLUSIONOral statins can significantly delay the clinical progression of BPH and LUTS.
Aged ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; therapeutic use ; Longitudinal Studies ; Lower Urinary Tract Symptoms ; drug therapy ; Male ; Middle Aged ; Prostatic Hyperplasia ; drug therapy ; Retrospective Studies